Implementation of a medicine management plan to reduce medication-related harm in older people post-hospital discharge- an RCT.

Poster ID
1285
Authors' names
Khalid Ali 1,2, Ekow A Mensah1, Eugene Ace McDermott1, Jennifer Stevenson3, Victoria Hamer, Nikesh Parekh1 , Rebekah Schiff3, Tischa Van Der Cammen4, Stephen Nyangoma5 , Sally Fowler-Davis6, Graham Davies3 , Heather Gage7, Chakravarthi Rajkumar 1
Author's provenances
1 Brighton and Sussex Medical School 2 University Hospitals Sussex 3 Guys and St Thomas’s NHS Foundation 4 Delft University 5 Imperial College, 6 Sheffield-Hallam University, 7 Surrey University

Abstract

Introduction

Medication-related harm (MRH) events are increasing among older adults especially in the 8-weeks after hospital discharge. The Discharge Medical Service (DMS), a UK initiative, aims to reduce post-discharge MRH. In this study, we will compare the clinical, economic, and service outcomes of the DMS.

Method

Using a randomized control trial design, 682 older adults ≥ 65years due for hospital-discharge will be recruited. Participants will be randomized to either intervention arm (medicine management plan (MMP) and DMS), or control arm (DMS only) using a 1:1 stratification. The MMP includes patient and carer education about MRH, copy of discharge medications, and MRH risk score calculated using a validated prediction tool (1). Data collection includes patient clinical and social demographics, and admission and discharge medications. At 8-weeks post discharge, study pharmacist will verify MRH through patient telephone interview, and review of patients’ GP records. Data Analysis Univariate analysis will be done for baseline variables comparing the intervention and control arms. Variables known to be associated with MRH will be described by the randomisation groups. Further multivariate logistic regression will be done incorporating these variables. Economic evaluation will compare the cost-of-service use among the two arms and modelled to provide national estimates. Qualitative data from focus group interviews at participating hospital sites will explore practitioners’ understanding and acceptance of the DMS and MMP.

Conclusion

This study will inform the use of a validated MRH risk prediction tool, and provide a clinical, and economic evaluation of the DMS and MMP in the NHS. The study has ethics approval and is adopted in the national ageing research portfolio. We are seeking additional sites. Reference 1. Parekh N, Ali K, Davies JG, et al. Medication-related harm in older adults following hospital discharge: development and validation of a prediction tool. BMJ Quality & Safety 2020; 29:142-153.

Comments

Good description of a planned study

Well written

It plans to find the best way to reduce medication related harm

How will this study fit in with what many sites are already doing along these lines as potential bias is there and some sites may be very happy with their intervention and not keen to try anything new. Something for you to consider

Well done

Submitted by Dr Asangaedem Akpan on

Permalink